Health, Medical & Pharma News - Updated Daily page 362

Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19

For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation with heparins is associated with lower 28-da

FDA Approves Generic GLP-1 Medicine For Diabetes Treatment

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living

Could AI Plus Lasers Help Catch Very Early Breast Cancers?

Very early-stage breast cancers are notoriously tough to spot via mammograms, but new technology might make detection easier. According to a new study published

Women Are Less Likely Than Men to Take Medication After a Stroke, Study Suggests

Female stroke victims are less likely than men to take drugs that could lower their odds of a second stroke. Women are 80 more likely to report that they don t

Northwest Naturals Pet Food Linked to Bird Flu in Cat, Issues Recall

A batch of pet food has been voluntarily recalled nationwide after a cat in Oregon died of bird flu, an illness state officials linked to contaminated food. The

Food Recall Update: Class 1 Alert Issued for Costco Eggs Linked to Salmonella

The U.S. Food and Drug Administration (FDA) has escalated the recall of certain eggs sold at Costco to its highest Class 1 alert level due to salmonella contami

Last Year's Platinum-Based Drugs Shortage Didn't Raise Cancer Deaths, Study Found

When supplies of certain generic, platinum-based cancer chemotherapies dwindled in 2023, oncologists feared it might lead to under-treatment and many more cance

Too Much Acetaminophen Could Harm Seniors' Health

New British research shows that too much of a good medication can be a bad thing.In the study, repeated doses of paracetamol, known as acetaminophen (brand name

Tea and Coffee May Help Protect You From Some Cancers

drinking decaf coffee was associated with a 25 lower risk of mouth cancer, results show.Previous studies have found that coffee drinking suppresses biological a

Genentech’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson’s Disease

Genentech, a member of the Roche Group (SIX RO, ROG OTCQX RHHBY) announced today results from the Phase IIb PADOVA study investigating prasinezumab in 586 peopl

Pharmaceutical News and Articles